Physician profile
April E Bowers
NPI 1710178348
$1,362.51
in general payments reported to CMS, 2019-2025
13 companies · $86.69 in 2025
The $86.69 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $82.55 · 2022: $482 · 2023: $559 · 2024: $152 · 2025: $86.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $798.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $480.64 | 2022-2024 | Epclusa, Livdelzi |
| Celgene Corporation | $157.29 | 2022-2024 | Zeposia |
| Abbvie INC. | $130.96 | 2022-2023 | |
| Janssen Scientific Affairs, LLC | $125.00 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $103.88 | 2021-2025 | Eliquis |
| Eisai INC. | $98.00 | 2022 | |
| Alkermes, INC. | $65.36 | 2025 | Vivitrol |
| Janssen Biotech, INC. | $59.56 | 2023 | Stelara |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.02 | 2022-2023 | Trulance |
| Exact Sciences Corporation | $29.01 | 2023 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.93 | 2023 | Cyltezo |
| Pfizer INC. | $15.95 | 2023 | |
| Ferring Pharmaceuticals INC. | $15.91 | 2023 | Clenpiq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Bowers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.